Product information and disease descriptionPlace of product in therapyDisease description
Burden of Essential tremor
7 evidence topics · 9 sources
Economic impact of diagnostic testing
Not applicable.
Ulixacaltamide
Essential tremor
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted by February 2026
- Launch
- Not announced
- Last updated